IL6 and Miyoshi myopathy: Subsequent knock-in of human IL-6, an important growth factor for human MM cells, generated an immunodeficient mouse strain in which cells derived from patients with MM or precursor lesions could be xenografted successfully and subsequently used for biomedical research (Das et al., 2017).